- Home
- ARTW vs EVAX Comparison
ARTW vs EVAX Comparison
Compare ARTW & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARTW | EVAX |
|---|---|---|
| Founded | 1956 | 2008 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9M | 42.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARTW | EVAX |
|---|---|---|
| Price | $2.25 | $4.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.33 |
| AVG Volume (30 Days) | 25.6K | ★ 105.1K |
| Earning Date | 10-07-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $24,079,949.00 | $7,650,000.00 |
| Revenue This Year | N/A | $128.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.69 | ★ N/A |
| Revenue Growth | N/A | ★ 132.17 |
| 52 Week Low | $1.43 | $1.20 |
| 52 Week High | $4.71 | $12.15 |
Technical Indicators
Market Signals| Indicator | ARTW | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | 42.73 | 39.17 |
| Support Level | $2.18 | $5.72 |
| Resistance Level | $2.55 | $6.70 |
| Average True Range (ATR) | 0.13 | 0.52 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 10.81 | 5.22 |
Price Performance
Historical ComparisonAbout ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.